CALGARY, Nov. 16, 2018 /CNW/ – Pond Technologies Holdings Inc. (TSXV: POND) announces it is seeking approval from the TSX Venture Exchange to extend the expiry date of six tranches of outstanding warrants, all issued on January 30, 2018, as part of a business combination with Pond Technologies Inc. by way of a three-cornered amalgamation previously announced on January 31, 2018.
The first tranche includes warrants exercisable to purchase 335,000 common shares of Pond at $2.50 per share, with an original expiry date of December 21, 2018; the second tranche includes warrants exercisable to purchase 450,000 common shares of Pond at $2.50 per share, with an original expiry date of February 23, 2019; the third tranche includes warrants exercisable to purchase 20,000 common shares of Pond at $2.50 per share, with an original expiry date of February 24, 2019; the fourth tranche includes warrants exercisable to purchase 240,000 common shares of Pond at $2.50 per share, with an original expiry date of September 21, 2019; The fifth tranche includes warrants exercisable to purchase 1,000,000 common shares of Pond at $3.00 per share, with an original expiry date of December 28, 2019; and the sixth tranche includes warrants exercisable to purchase 2,644,279 common shares of Pond at $3.00 per share, with an original expiry date of December 30, 2020. If approved, the expiry date of all six tranches of warrants will be extended to January 30, 2021. All other terms and conditions of each tranche of the warrants remain unchanged.
About Pond Technologies:
Located in Markham Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of pollution abatement and nutrition. Pond’s proprietary growth platform optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms. It enables industrial emitters to generate new revenue streams from the transformation of waste CO2 to valuable algae-based products used as proteins for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
SOURCE Pond Technologies Holdings Inc.
For further information: Chris Cory at c.cory@pondtech.com, 416-287-3835 x-215